| Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials JR Campbell, A Trajman, VJ Cook, JC Johnston, M Adjobimey, R Ruslami, ... The Lancet Infectious Diseases 20 (3), 318-329, 2020 | 54 | 2020 |
| Prevalence of latent tuberculosis infection in Syrian refugees to Canada P Warrington, G Tyrrell, K Choy, L Eisenbeis, R Long, R Cooper Canadian Journal of Public Health 109, 8-14, 2018 | 14 | 2018 |
| Contact investigation outcomes of Canadian-born adults with tuberculosis in Indigenous and non-Indigenous populations in Alberta L Eisenbeis, Z Gao, C Heffernan, W Yacoub, R Long, G Verma Canadian Journal of Public Health 107, e106-e111, 2016 | 8 | 2016 |
| Examination of care milestones for preventing congenital syphilis transmission among syphilis-infected pregnant women in Alberta, Canada: 2017–2019 JM Round, SS Plitt, L Eisenbeis, P Smyczek, J Gratrix, C Charlton, ... Sexually Transmitted Diseases 49 (7), 477-483, 2022 | 4 | 2022 |
| Factors Associated With Discontinuation of Tuberculosis Preventive Treatment: Post Hoc Analysis of 2 Randomized, Controlled Trials A Allard-Gray, I Boakye, A Camara, L Eisenbeis, E Guimarães-Teixeira, ... Clinical Infectious Diseases 77 (1), 84-93, 2023 | | 2023 |
| Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials A Trajman, JR Campbell, JC Johnston, D Menzies, VJ Cook, M Adjobimey, ... | | 2020 |
| Comparing contact investigations of tuberculosis cases among the Canadian Born Aboriginal and non-Aboriginal population in Alberta, Canada LM Eisenbeis | | 2015 |
